These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16148496)

  • 1. MRSA pneumonia: better outcome through continuous infusion of vancomycin?
    Blot S
    Crit Care Med; 2005 Sep; 33(9):2127-8. PubMed ID: 16148496
    [No Abstract]   [Full Text] [Related]  

  • 2. What does it mean: appropriate therapy for methicillin-resistant Staphylococcus aureus?
    Viale P; Pea F
    Crit Care Med; 2007 Mar; 35(3):991; author reply 991-2. PubMed ID: 17421115
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen?
    Rello J; Mallol J
    Chest; 2006 Oct; 130(4):938-40. PubMed ID: 17035421
    [No Abstract]   [Full Text] [Related]  

  • 4. Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia.
    Hall RG; Adams-Huet B
    Chest; 2007 Sep; 132(3):1100-1; author reply 1102-3. PubMed ID: 17873214
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
    Wenisch C; Laferl H; Szell M; Smolle KH; Grisold A; Bertha G; Krause R
    Infection; 2006 Jun; 34(3):148-54. PubMed ID: 16804658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
    Jeffres MN; Isakow W; Doherty JA; McKinnon PS; Ritchie DJ; Micek ST; Kollef MH
    Chest; 2006 Oct; 130(4):947-55. PubMed ID: 17035423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstein R
    Clin Ther; 2007 Feb; 29(2):381-3; author reply 383-4. PubMed ID: 17472831
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstem R
    Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
    Humphreys H; Smyth EG
    J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985
    [No Abstract]   [Full Text] [Related]  

  • 11. Methicillin-resistant Staphylococcus aureus pneumonia treatment: do not confuse pharmacokinetics and pharmacodynamics.
    Moine P; Bédos JP
    Chest; 2007 Sep; 132(3):1101, author reply 1102-3. PubMed ID: 17873216
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of methicillin-resistant Staphylococcus aureus pneumonia.
    Luna CM; Boyeras Navarro ID
    Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia.
    Potoski BA; Paterson DL
    Chest; 2007 Sep; 132(3):1101-2; author reply 1102-3. PubMed ID: 17873215
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospital-acquired pneumonia: methicillin resistance and intensive care unit admission.
    Fagon JY; Maillet JM; Novara A
    Am J Med; 1998 May; 104(5A):17S-23S. PubMed ID: 9684654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.
    Scheetz MH; Wunderink RG; Postelnick MJ; Noskin GA
    Pharmacotherapy; 2006 Apr; 26(4):539-50. PubMed ID: 16553514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Wunderink RG; Rello J; Cammarata SK; Croos-Dabrera RV; Kollef MH
    Chest; 2003 Nov; 124(5):1789-97. PubMed ID: 14605050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD; Goldstein FW
    Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Daniel Mullins C; Kuznik A; Shaya FT; Obeidat NA; Levine AR; Liu LZ; Wong W
    Clin Ther; 2006 Aug; 28(8):1184-1198. PubMed ID: 16982296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial pneumonia: therapy is just not good enough.
    Bauer TT
    Chest; 2003 Nov; 124(5):1632-4. PubMed ID: 14605025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.